The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes.

Highlights include:

• The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transparency and accountability
• Why effective AI governance requires cross-functional collaboration and continuous trade-off assessment
• How leveraging AI to enhance workflows can drive efficiency and effectiveness but must be implemented thoughtfully with the right controls in place

As senior vice president of customer distribution experience at McKesson, Ammie McAsey makes it a point to connect her day-to-day work with the company’s mission of improving healthcare in every setting. Learn how she’s working to connect the healthcare ecosystem to bring additional access and benefits to patients. Highlights include:

• Her view of the opportunities for collaboration to build a better healthcare value chain
• Discussion of how we can improve the patient’s experience
• Areas where she sees the most potential for innovation across healthcare

Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients.

Highlights include:

• Why partnerships are an important part of this journey
• How a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosis
• Why pharma leaders should experiment with new technologies to drive real change and innovation